SG11201808700QA - Large scale pei-mediated plasmid transfection - Google Patents
Large scale pei-mediated plasmid transfectionInfo
- Publication number
- SG11201808700QA SG11201808700QA SG11201808700QA SG11201808700QA SG11201808700QA SG 11201808700Q A SG11201808700Q A SG 11201808700QA SG 11201808700Q A SG11201808700Q A SG 11201808700QA SG 11201808700Q A SG11201808700Q A SG 11201808700QA SG 11201808700Q A SG11201808700Q A SG 11201808700QA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- rule
- pei
- kuopio
- transfection
- Prior art date
Links
- 238000001890 transfection Methods 0.000 title abstract 7
- 239000013612 plasmid Substances 0.000 title abstract 4
- 230000001404 mediated effect Effects 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 239000002609 medium Substances 0.000 abstract 3
- 238000004115 adherent culture Methods 0.000 abstract 1
- 230000001464 adherent effect Effects 0.000 abstract 1
- 238000013459 approach Methods 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000012737 fresh medium Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/18—External loop; Means for reintroduction of fermented biomass or liquid percolate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/02—Apparatus for enzymology or microbiology with agitation means; with heat exchange means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/16—Particles; Beads; Granular material; Encapsulation
- C12M25/18—Fixed or packed bed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/46—Means for regulation, monitoring, measurement or control, e.g. flow regulation of cellular or enzymatic activity or functionality, e.g. cell viability
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Clinical Laboratory Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 11111 1411 0 11101 010 11111 01 100011101110 MIN 11111 00 11110 110 HMI Organization International Bureau (10) International Publication Number (43) International Publication Date .....0\"\" WO 2018/007873 A4 11 January 2018 (11.01.2018) W I PO I PCT — (51) (21) (22) (25) Filing Language: (26) (30) (71) (71) International Patent Classification: C12N 15/86 (2006.01) International Application International Filing Date: Publication Language: Priority Data: 62/322,651 14 April 2016 (14.04.2016) PCT/US2017/025681 04 April 2017 (04.04.2017) Applicant: TRIZELL LTD. Oakley Road, Chinnor OX39 4TW (GB). (72) Inventors: LESCH, Hanna; Microkatu 1 s, FIN-70210 Kuopio (FI). VALKAMA, Anniina; Microkatu 1s, Number: FIN-70210 Kuopio (FI). MALINEN, Joonas; Microkatu PCT/IB2017/001205 ls, FIN-70210 Kuopio (FI). LIPPONEN, Eevi; Microkatu 1s, FIN-70210 Kuopio (FI). LEINONEN, Hanna; Mi- crokatu 1, Kuopio (FI). 25 April 2017 (25.04.2017) (74) Agent: PHARMACEUTICAL PATENT ATTOR- English NEYS, LLC; 55 Madison Ave, 4th Floor, Morristown, NJ 07960-7397 (US). English (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, US AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, US DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, [GB/GB]; Sanderum House HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PHARMACEUTICAL PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, LLC [US/US]; 55 Madison SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, NJ 07960-7397 (US). TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. Applicant (for US only): PATENT ATTORNEYS, Ave, 4th Floor, Morristown, (54) ,1 precipitate 0 transfection Title: LARGE SCALE PEI-MEDIATED PLASMID TRANSFECTION pump titer viral vectors of the PEI-plasmid improve PEI-based high A. Recirculation of the medium Medium c mtaining Tra nsfection Mix iCELLis500 Bioreactor = pump a way to = — = — _ = = B. Perfusion of the medium = = fixed Figure 2 : We have found a bed or adherent cell culture which in prior art approaches by modifying how pH pump by using PEI as a transfection adherent — 0- iCELLis500 Bioreactor = Fresh Medium Used me( I i H r 1 = pump agent, We have also found plasmid transfection way to make possible bioreactors clogged and CO2 are managed using PEI to produce while avoiding formation 71' IN en GC IN © c ::: :) (57) -- -- GC in ei large-scale during transfection. bioreactor substrates. C [Continued on next page] WO 2018/007873 A4 MIDEDIMOMOIDEIREEMOOMOVIEDEIIHMEION (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — as to the identity of the inventor (Rule 4.17(1)) — as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(11)) — as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) — with amended claims (Art. 19(1)) — the filing date of the international application is within two months from the date of expiration of the priority period (Rule 26bis.3) Date of publication of the amended claims: 01 March 2018 (01.03.2018)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662322651P | 2016-04-14 | 2016-04-14 | |
PCT/US2017/025681 WO2017180341A2 (en) | 2016-04-14 | 2017-04-03 | Fixed-bed bioreactor with constant-flow pump/ tubing system |
PCT/IB2017/001205 WO2018007873A1 (en) | 2016-04-14 | 2017-04-25 | Large scale pei-mediated plasmid transfection |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201808700QA true SG11201808700QA (en) | 2018-11-29 |
Family
ID=66522911
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202110989QA SG10202110989QA (en) | 2017-04-03 | 2017-04-25 | Large scale pei-mediated plasmid transfection |
SG11201808700QA SG11201808700QA (en) | 2016-04-14 | 2017-04-25 | Large scale pei-mediated plasmid transfection |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202110989QA SG10202110989QA (en) | 2017-04-03 | 2017-04-25 | Large scale pei-mediated plasmid transfection |
Country Status (9)
Country | Link |
---|---|
US (3) | US11261416B2 (en) |
EP (1) | EP3497224B1 (en) |
KR (3) | KR20230022177A (en) |
CN (2) | CN116144500A (en) |
CA (1) | CA3021045A1 (en) |
ES (1) | ES2951678T3 (en) |
FI (1) | FI3497224T3 (en) |
SG (2) | SG10202110989QA (en) |
WO (1) | WO2018007873A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201808698TA (en) | 2016-04-14 | 2018-11-29 | Trizell Ltd | Fixed-bed bioreactor with constant-flow pump/ tubing system |
CN116144500A (en) | 2016-04-14 | 2023-05-23 | 崔泽尔有限公司 | Fixed bed bioreactor with constant flow pump/pipe system |
BE1026108B1 (en) * | 2018-03-16 | 2019-10-14 | Univercells S.A. | FIXED BED SAMPLE AND ASSOCIATED METHODS |
US20190292609A1 (en) * | 2019-05-30 | 2019-09-26 | Trizell Ltd. | Gene Therapy Vector Contamination Assay |
JP2023524148A (en) | 2020-05-04 | 2023-06-08 | エージーシー バイオロジクス エス.ピー.エー. | Lentiviral vector production process in a packed bed bioreactor |
CN112779226A (en) * | 2021-02-03 | 2021-05-11 | 苏州博腾生物制药有限公司 | Culture process of lentivirus adherent cells |
CN114317395B (en) * | 2021-12-31 | 2024-04-02 | 中国肉类食品综合研究中心 | Large-scale culture process for adherent cells |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63313576A (en) | 1987-06-13 | 1988-12-21 | Rikagaku Kenkyusho | Tubular bio-reactor |
US5622857A (en) | 1995-08-08 | 1997-04-22 | Genespan Corporation | High performance cell culture bioreactor and method |
AU732703B2 (en) * | 1996-11-20 | 2001-04-26 | Crucell Holland B.V. | An improved method for the production and purification of adenoviral vectors |
AU2003212521B2 (en) | 2002-03-12 | 2006-10-05 | Ark Therapeutics Ltd. | Engineered baculoviruses and their use |
JP2007525984A (en) | 2004-03-05 | 2007-09-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | Cell culture method by continuous perfusion and alternating tangential flow |
US20110189764A1 (en) * | 2011-03-27 | 2011-08-04 | Nathan Starbard | Single use device incorporating a container and scaffold |
CA2901940A1 (en) | 2013-02-22 | 2014-08-28 | Genzyme Corporation | Microcarrier perfusion culturing methods and uses thereof |
RU2768003C2 (en) * | 2013-03-08 | 2022-03-22 | Джензим Корпорейшн | Integrated continuous production of therapeutic protein-based medicinal agents |
GB201417042D0 (en) * | 2014-09-29 | 2014-11-12 | Fkd Therapies Oy | Method |
US20160257972A1 (en) * | 2015-03-04 | 2016-09-08 | Children's Hospital Medical Center | Foamy viral vector compositions and methods for the manufacture of same |
SG11201808698TA (en) | 2016-04-14 | 2018-11-29 | Trizell Ltd | Fixed-bed bioreactor with constant-flow pump/ tubing system |
CN116144500A (en) | 2016-04-14 | 2023-05-23 | 崔泽尔有限公司 | Fixed bed bioreactor with constant flow pump/pipe system |
-
2017
- 2017-04-03 CN CN202310104669.4A patent/CN116144500A/en active Pending
- 2017-04-03 US US15/579,208 patent/US11261416B2/en active Active
- 2017-04-03 KR KR1020227044118A patent/KR20230022177A/en not_active Application Discontinuation
- 2017-04-25 CN CN201780023080.4A patent/CN109072252A/en active Pending
- 2017-04-25 FI FIEP17791136.9T patent/FI3497224T3/en active
- 2017-04-25 EP EP17791136.9A patent/EP3497224B1/en active Active
- 2017-04-25 KR KR1020247003513A patent/KR20240025689A/en not_active Application Discontinuation
- 2017-04-25 ES ES17791136T patent/ES2951678T3/en active Active
- 2017-04-25 SG SG10202110989QA patent/SG10202110989QA/en unknown
- 2017-04-25 CA CA3021045A patent/CA3021045A1/en active Pending
- 2017-04-25 WO PCT/IB2017/001205 patent/WO2018007873A1/en active Application Filing
- 2017-04-25 SG SG11201808700QA patent/SG11201808700QA/en unknown
- 2017-04-25 KR KR1020187032283A patent/KR20190039021A/en not_active IP Right Cessation
-
2019
- 2019-03-19 US US16/357,532 patent/US11242504B2/en active Active
-
2021
- 2021-12-22 US US17/559,366 patent/US20220364036A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220364036A1 (en) | 2022-11-17 |
WO2018007873A4 (en) | 2018-03-01 |
US20190031998A1 (en) | 2019-01-31 |
EP3497224B1 (en) | 2023-06-07 |
US11242504B2 (en) | 2022-02-08 |
US20190218495A1 (en) | 2019-07-18 |
US11261416B2 (en) | 2022-03-01 |
KR20240025689A (en) | 2024-02-27 |
EP3497224A1 (en) | 2019-06-19 |
WO2018007873A1 (en) | 2018-01-11 |
KR20190039021A (en) | 2019-04-10 |
CA3021045A1 (en) | 2018-01-11 |
FI3497224T3 (en) | 2023-08-17 |
CN109072252A (en) | 2018-12-21 |
CN116144500A (en) | 2023-05-23 |
KR20230022177A (en) | 2023-02-14 |
ES2951678T3 (en) | 2023-10-24 |
SG10202110989QA (en) | 2021-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201808700QA (en) | Large scale pei-mediated plasmid transfection | |
SG11201908658TA (en) | Nucleobase editors comprising nucleic acid programmable dna binding proteins | |
SG11201808721YA (en) | Cell-free production of ribonucleic acid | |
SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
SG11201906161VA (en) | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells | |
SG11201810780XA (en) | Single use bioreactor | |
SG11201810286WA (en) | Variable diameter bioreactors | |
SG11201805835WA (en) | Modified oncolytic virus | |
SG11201909331UA (en) | Antigen-specific immune effector cells | |
SG11201906763RA (en) | Pyrrolo [1,2-b] pyridazine derivatives | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201804375WA (en) | Compositions and methods for internalizing enzymes | |
SG11201809710RA (en) | Genetically engineered cells and methods of making the same | |
SG11201900049QA (en) | Crispr/cas9-based compositions and methods for treating retinal degenerations | |
SG11201806988UA (en) | Improved differentiation method | |
SG11201805451TA (en) | Immune effector cell therapies with enhanced efficacy | |
SG11201804070XA (en) | Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a | |
SG11201803169WA (en) | Cellulase variants and polynucleotides encoding same | |
SG11201804710TA (en) | Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof | |
SG11201811232XA (en) | Treatment of amd using aav2 variant with aflibercept | |
SG11201407970VA (en) | Modulation of hepatitis b virus cccdna transcription | |
SG11201903428XA (en) | Pluripotent stem cell assay | |
SG11201909087PA (en) | Perfusion medium | |
SG11201805052YA (en) | Therapeutic methods using erythrocytes | |
SG11201810088SA (en) | Recovering long-range linkage information from preserved samples |